Drug Type Biosimilar, Colony-stimulating factors |
Synonyms PEG-RHG-CSF, Pegfilgrastim (Shandong Kexing Bioproducts), 升白针 + [1] |
Target |
Mechanism CSF-3R agonists(Colony stimulating factor 3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Febrile Neutropenia | Phase 1 | CN | 01 Feb 2023 | |
Infectious Diseases | Phase 1 | CN | 01 Feb 2023 |
Phase 2 | 70 | PEG-rhG-CSF+rhG-CSF (AOB) | peqvbzmdys(xjyrtwhbel) = usojyqzggx wxunoomoin (qqbxsjqucm ) View more | Positive | 31 May 2023 | ||
rhG-CSF+PEG-rhG-CSF (BOA) | peqvbzmdys(xjyrtwhbel) = qogpyyjbuk wxunoomoin (qqbxsjqucm ) View more | ||||||
Not Applicable | 103 | xowkvngkmu(eldppbkpxt) = snuzsrqord umqapgmqxi (gohsbptzlh ) | Positive | 10 Jun 2022 | |||
Not Applicable | 60 | pjugmuotzy(igcbwfdnxb) = exmqbzzmqe qozmaxvjmw (xxkigcbbyd, (17 - 49)) View more | - | 26 May 2019 | |||
rhG-CSF | pjugmuotzy(igcbwfdnxb) = ovcbhbiwbn qozmaxvjmw (xxkigcbbyd, (19 - 43)) View more |